Cargando…
Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis
Visceral leishmaniasis is a protozoan disease associated with high fatality rate in developing countries. Although the drug pipeline is constantly improving, available treatments are costly and live-threatening side effects are not uncommon. Moreover, an approved vaccine against human leishmaniasis...
Autores principales: | Helou, Doumet Georges, Mauras, Aurélie, Fasquelle, François, Lanza, Juliane Sousa, Loiseau, Philippe M., Betbeder, Didier, Cojean, Sandrine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370633/ https://www.ncbi.nlm.nih.gov/pubmed/34403413 http://dx.doi.org/10.1371/journal.pntd.0009627 |
Ejemplares similares
-
Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani
por: Morimoto, Ayako, et al.
Publicado: (2016) -
Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani
por: Duthie, Malcolm S, et al.
Publicado: (2019) -
Synthesis and Antileishmanial Activity of 1,2,4,5-Tetraoxanes against Leishmania donovani
por: Cabral, Lília I. L., et al.
Publicado: (2020) -
Risk Factors for Visceral Leishmaniasis and Asymptomatic Leishmania donovani Infection in India and Nepal
por: Picado, Albert, et al.
Publicado: (2014) -
Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis
por: Jamal, Fauzia, et al.
Publicado: (2017)